Suppr超能文献

盐酸文拉法辛从压制包衣骨架片中释放的调控

Modulation of venlafaxine hydrochloride release from press coated matrix tablet.

作者信息

Gohel M C, Soni C D, Nagori S A, Sarvaiya K G

机构信息

Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Navrangpura, Ahmedabad-380 009, India.

出版信息

Indian J Pharm Sci. 2008 May-Jun;70(3):292-7. doi: 10.4103/0250-474X.42974.

Abstract

The aim of present study was to prepare novel modified release press coated tablets of venlafaxine hydrochloride. Hydroxypropylmethylcellulose K4M and hydroxypropylmethylcellulose K100M were used as release modifier in core and coat, respectively. A 3(2) full factorial design was adopted in the optimization study. The drug to polymer ratio in core and coat were chosen as independent variables. The drug release in the first hour and drug release rate between 1 and 12 h were chosen as dependent variables. The tablets were characterized for dimension analysis, crushing strength, friability and in vitro drug release. A check point batch, containing 1:2.6 and 1:5.4 drug to polymer in core and coat respectively, was prepared. The tablets of check point batch were subjected to in vitro drug release in dissolution media with pH 5, 7.2 and distilled water. The kinetics of drug release was best explained by Korsmeyer and Peppas model (anomalous non-Fickian diffusion). The systematic formulation approach enabled us to develop modified release venlafaxine hydrochloride tablets.

摘要

本研究的目的是制备新型盐酸文拉法辛控释压制包衣片。羟丙基甲基纤维素K4M和羟丙基甲基纤维素K100M分别用作片芯和包衣的释放调节剂。在优化研究中采用了3(2)全因子设计。将片芯和包衣中的药物与聚合物比例选为自变量。将第1小时的药物释放和1至12小时之间的药物释放速率选为因变量。对片剂进行尺寸分析、抗压强度、脆碎度和体外药物释放特性研究。制备了一个检查点批次的片剂,其片芯和包衣中药物与聚合物的比例分别为1:2.6和1:5.4。将检查点批次的片剂在pH值为5、7.2的溶出介质和蒸馏水中进行体外药物释放研究。药物释放动力学最适合用Korsmeyer和Peppas模型(非菲克反常扩散)来解释。系统的制剂方法使我们能够开发出盐酸文拉法辛控释片。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/47849c64c696/IJPhS-70-292-g001.jpg

相似文献

1
Modulation of venlafaxine hydrochloride release from press coated matrix tablet.
Indian J Pharm Sci. 2008 May-Jun;70(3):292-7. doi: 10.4103/0250-474X.42974.
2
Press-Coated Aceclofenac Tablets for Pulsatile Drug Delivery: Formulation and In Vitro Evaluations.
Pharmaceuticals (Basel). 2022 Mar 8;15(3):326. doi: 10.3390/ph15030326.
4
Development of Bioadhesive Buccal Tablets of Nicorandil Using a Factorial Approach.
Turk J Pharm Sci. 2020 Aug;17(4):388-397. doi: 10.4274/tjps.galenos.2019.09226. Epub 2020 Aug 28.
6
In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Drug Dev Ind Pharm. 2013 Nov;39(11):1651-62. doi: 10.3109/03639045.2012.729146. Epub 2012 Oct 24.
7
9
Formulation development of carvedilol compression coated tablet.
Pharm Dev Technol. 2013 Jul-Aug;18(4):906-15. doi: 10.3109/10837450.2011.598167. Epub 2011 Jul 28.

引用本文的文献

1
Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet.
AAPS PharmSciTech. 2010 Sep;11(3):1026-37. doi: 10.1208/s12249-010-9467-z. Epub 2010 Jun 8.

本文引用的文献

1
Design and study of rifampicin oral controlled release formulations.
Drug Deliv. 2004 Sep-Oct;11(5):311-7. doi: 10.1080/10717540490494087.
2
4
Analysis of data on the medicament release from ointments.
J Pharm Sci. 1962 Aug;51:802-4. doi: 10.1002/jps.2600510825.
5
Rate of release of medicaments from ointment bases containing drugs in suspension.
J Pharm Sci. 1961 Oct;50:874-5. doi: 10.1002/jps.2600501018.
6
New methods characterizing avalanche behavior to determine powder flow.
Pharm Res. 2002 Jun;19(6):887-93. doi: 10.1023/a:1016125420577.
7
Once daily sustained release tablets of venlafaxine, a novel antidepressant.
Eur J Pharm Biopharm. 2002 Jul;54(1):9-15. doi: 10.1016/s0939-6411(02)00049-8.
9
Venlafaxine. A review of its pharmacology and therapeutic potential in depression.
Drugs. 1995 Feb;49(2):280-94. doi: 10.2165/00003495-199549020-00010.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验